Abstract
Diabetes Mellitus (DM) affects over 693 million adults globally by 2045, with complications like neuropathy underscoring the need for effective monitoring. This observational case-control study at Ibnu Sina Hospital, Makassar, explores the relationship between HbA1c levels, fasting blood sugar (GDP), disease duration, and diabetic neuropathy. Analyzing 77 medical records, the study found that most participants were aged 56-65 years, predominantly male, with high rates of uncontrolled HbA1c (80.5%) and GDP (67.5%). Diabetic neuropathy prevalence was 61.0%. Statistical analysis revealed significant correlations between neuropathy and HbA1c levels (p=0.000), GDP (p=0.002), and disease duration (p=0.041). These findings highlight the impact of glycemic control and disease duration on neuropathy in DM patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
